Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
Add more filters










Publication year range
1.
Physiol Res ; 63(Suppl 4): S601-12, 2014.
Article in English | MEDLINE | ID: mdl-25669691

ABSTRACT

Several pre-clinical and clinical studies have demonstrated zoledronic acid (Zol), which regulates the mevalonate pathway, has efficient anti-cancer effects. Zol can also induce autophagy. The aim of this study is to add new understanding to the mechanism of autophagy induction by Zol. LC3B-II, the marker for autophagy was increased by Zol treatment in breast cancer cells. Autophagosomes induced by Zol were visualized and quantified in both transient (pDendra2-hLC3) and stable MCF-7-GFP-LC3 cell lines. Acidic vesicular organelles were quantified using acridine orange. Zol induced a dose and time dependent autophagy. Treatment of Zol increased oxidative stress in MCF-7 cells, which was reversed by GGOH or anti-oxidants. On the other hand, treatment with GGOH or anti-oxidants resulted in decreased levels of LC3B-II. Further, the induced autophagy was irreversible, as the washout of Zol after 2 h or 24 h resulted in similar levels of autophagy, as induced by continuous treatment after 72 h. Thus, it can be summarized that Zol can induce a dose dependent but irreversible autophagy, by its effect on the mevalonate pathway and oxidative stress. This study adds to the understanding of the mechanism of action of Zol, and that it can induce autophagy at clinically relevant shorter exposure times in cancer cells.


Subject(s)
Autophagy/drug effects , Bone Density Conservation Agents/therapeutic use , Breast Neoplasms/drug therapy , Diphosphonates/therapeutic use , Imidazoles/therapeutic use , Oxidative Stress/drug effects , Bone Density Conservation Agents/pharmacology , Breast Neoplasms/metabolism , Diphosphonates/pharmacology , Humans , Imidazoles/pharmacology , MCF-7 Cells , Mevalonic Acid/metabolism , Zoledronic Acid
2.
Oncogene ; 31(5): 624-33, 2012 Feb 02.
Article in English | MEDLINE | ID: mdl-21725361

ABSTRACT

We have recently shown that the adaptor protein p140Cap regulates tumor properties in terms of cell motility and growth. Here, by using the highly metastatic rat adenocarcinoma cell line MTLn3-epidermal growth factor receptor (EGFR), we assess the role of p140Cap in metastasis formation. Orthotopic transplantation of MTLn3-EGFR cells over-expressing p140Cap in Rag2(-/-)γ(c)(-/-) mice resulted in normal primary tumor growth compared with the controls. Strikingly, p140Cap over-expression causes an 80% inhibition in the number of lung metastases. p140Cap over-expressing cells display a 50% reduction in directional cell migration, an increased number and size of focal adhesions, and a strong impairment in the ability to invade in a 3D matrix. p140Cap over-expression affects EGFR signaling and tyrosine phosphorylation of cortactin in response to EGF stimulation. Intriguingly, p140Cap associates with cortactin via interaction with its second proline-rich domain to the cortactin SH3 domain. The phosphomimetic cortactin tyrosine 421 mutant rescues migration and invasive properties in p140Cap over-expressing cells. Taken together, these data demonstrate that p140Cap suppresses the invasive properties of highly metastatic breast carcinoma cells by inhibiting cortactin-dependent cell motility.


Subject(s)
Adaptor Proteins, Vesicular Transport/metabolism , Cortactin/metabolism , Mammary Neoplasms, Experimental/metabolism , Adaptor Proteins, Vesicular Transport/genetics , Adenocarcinoma/genetics , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Animals , Cell Line, Tumor , Cell Movement , Cortactin/genetics , Epidermal Growth Factor/pharmacology , ErbB Receptors/genetics , ErbB Receptors/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , HEK293 Cells , Humans , Immunohistochemistry , Lung Neoplasms/genetics , Lung Neoplasms/metabolism , Lung Neoplasms/secondary , Mammary Neoplasms, Experimental/genetics , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Knockout , Microscopy, Fluorescence, Multiphoton , Neoplasm Invasiveness , Neoplasm Metastasis , Neoplasm Transplantation , Phosphorylation/drug effects , Protein Binding , RNA Interference , Rats , Transplantation, Heterologous
4.
J Cell Sci ; 113 ( Pt 18): 3289-98, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10954426

ABSTRACT

Basophils and mast cells contain a peculiar class of inflammatory granules that discharge their content upon antigen-mediated crosslinking of IgE-membrane receptors. The pathways for granule biogenesis and exocytosis in these cells are still largely obscure. In this study we employed the rat basophilic leukemia (RBL)/mast cell line to verify the hypothesis that inflammatory granules share common bioactive molecules and functional properties with lysosomes. We demonstrate that inflammatory granules, as identified by the monoclonal 5G10 antibody (which recognises an integral membrane protein) or by Toluidine Blue staining, have an intralumenal acidic pH, possess lysosomal enzymes and are accessible by fluid-phase and membrane endocytosis markers. In addition, we studied the targeting, subcellular localisation and regulated secretion of the lysosomal aspartic protease cathepsin D (CD) as affected by IgE receptor stimulation in order to obtain information on the pathways for granule biogenesis and exocytosis. Stimulation with DNP-BSA of specific IgE-primed RBL cells led to a prompt release of processed forms of CD, along with other mature lysosomal hydrolases. This release could be prevented by addition of EGTA, indicating that it was dependent on extracellular calcium influx. Antigen stimulation also induced exocytosis of immature CD forms accumulated by ammonium chloride, suggesting the existence of an intermediate station in the pathway for granule biogenesis still sensitive to regulated exocytosis. The targeting of molecules to secretory granules may occur via either a mannose-6-phosphate-dependent or mannose-6-phosphate-independent pathway. We conclude that endosomes and lysosomes in basophils/mast cells can act as regulated secretory granules or actually identify with them.


Subject(s)
Basophils/immunology , Cathepsin D/immunology , Mast Cells/immunology , Animals , Antigens/immunology , Basophils/cytology , Calcium/immunology , Dinitrophenols/immunology , Endocytosis/immunology , Endosomes/metabolism , Exocytosis/immunology , Lysosomes/metabolism , Mannosephosphates/immunology , Mast Cells/cytology , Rats , Serum Albumin, Bovine/immunology , Tumor Cells, Cultured
5.
J Cell Sci ; 113 ( Pt 4): 741-8, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10652266

ABSTRACT

We show that in the rat basophilic leukemia cell line RBL, the physiological stimulation of the IgE receptor or direct activation of PKC leads to the missorting of proteins to the plasma membrane, diverting them from their normal intracellular destination. This is demonstrated for two classes of proteins that are normally targeted to the secretory lysosomes via completely different mechanisms, i.e. proteoglycans and the aspartic protease cathepsin D. In the latter case, normal processing of the enzyme is also affected, leading to secretion of the immature form of cathepsin. The present study shows how completely different sorting mechanisms, such as those for delivering proteoglycans and cathepsin D to secretory lysosomes, might share common regulatory signals and are similarly affected when the levels of these signals are perturbed. Finally, protein kinase C appears to be a major player in the signal transduction pathways, leading to proteoglycan and cathepsin D missorting.


Subject(s)
Cell Membrane/metabolism , Golgi Apparatus/metabolism , Receptors, IgE/metabolism , Animals , Biological Transport/drug effects , Biological Transport/physiology , Brefeldin A/pharmacology , Carcinogens/pharmacology , Cathepsin D/metabolism , Cell Membrane/chemistry , Cytoplasmic Granules/metabolism , Endopeptidases/metabolism , Fluorescent Antibody Technique , Glycosaminoglycans/metabolism , Leukemia, Basophilic, Acute , Lysosomes/enzymology , Protein Kinase C/metabolism , Protein Synthesis Inhibitors/pharmacology , Rats , Tetradecanoylphorbol Acetate/pharmacology , Tumor Cells, Cultured
6.
J Cell Biol ; 148(1): 45-58, 2000 Jan 10.
Article in English | MEDLINE | ID: mdl-10629217

ABSTRACT

Transport intermediates (TIs) have a central role in intracellular traffic, and much effort has been directed towards defining their molecular organization. Unfortunately, major uncertainties remain regarding their true structure in living cells. To address this question, we have developed an approach based on the combination of the green fluorescent protein technology and correlative light-electron microscopy, by which it is possible to monitor an individual carrier in vivo and then take a picture of its ultrastructure at any moment of its life-cycle. We have applied this technique to define the structure of TIs operating from the Golgi apparatus to the plasma membrane, whose in vivo dynamics have been characterized recently by light microscopy. We find that these carriers are large (ranging from 0.3-1.7 microm in maximum diameter, nearly half the size of a Golgi cisterna), comprise almost exclusively tubular-saccular structures, and fuse directly with the plasma membrane, sometimes minutes after docking to the fusion site.


Subject(s)
Cell Membrane/metabolism , Golgi Apparatus/metabolism , Membrane Glycoproteins , Animals , COS Cells , Cell Membrane/ultrastructure , Golgi Apparatus/ultrastructure , Humans , Microscopy, Electron/methods , Microtomy , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Viral Envelope Proteins/genetics , Viral Envelope Proteins/metabolism
7.
FEBS Lett ; 451(3): 315-20, 1999 May 28.
Article in English | MEDLINE | ID: mdl-10371212

ABSTRACT

In this report, we have investigated whether alterations of the morphological and functional aspects of the biosecretory membrane system are associated with the metastatic potential of tumor cells. To this end, we have analyzed the morphology of the Golgi complex, the cytoskeleton organization and membrane trafficking steps of the secretory pathway in two human melanoma A375 cell line variants with low (A375-P) and high metastatic (A375-MM) potential. Immunofluorescence analysis showed that in A375-P cells, the Golgi complex showed a collapsed morphology. Conversely, in A375-MM cells, the Golgi complex presented a reticular and extended morphology. At the ultrastructural level, the Golgi complex of A375-P cells was fragmented and cisternae were swollen. When the cytoskeleton was analyzed, the microtubular network appeared normal in both cell variants, whereas actin stress fibers were largely absent in A375-P, but not in A375-MM cells. In addition, the F-actin content in A375-P cells was significantly lower than in A375-MM cells. These morphological differences in A375-P cells were accompanied by acceleration and an increase in the endoplasmic reticulum to Golgi and the trans-Golgi network to cell surface membrane transport, respectively. Our results indicate that in human A375 melanoma cells, metastatic potential correlates with a well-structured morphofunctional organization of the Golgi complex and actin cytoskeleton.


Subject(s)
Cytoskeleton/pathology , Golgi Apparatus/pathology , Melanoma/metabolism , Melanoma/pathology , Skin Neoplasms/metabolism , Skin Neoplasms/pathology , Biological Transport , Humans , Neoplasm Invasiveness , Tumor Cells, Cultured
8.
Life Sci ; 64(10): 837-46, 1999.
Article in English | MEDLINE | ID: mdl-10096434

ABSTRACT

The selective immunosuppressants cyclosporin A (CsA) and tacrolimus (FK506) are used in the prevention of allogenic transplant rejection and in the therapy of chronic autoimmune inflammatory pathologies. Chronic treatment with CsA leads to secondary functional and trophic alterations of multiple organs and cell systems among which endocrine ones, through insofar uncharacterized mechanisms. With the recent use of FK506 there have been reports of an improved therapeutic efficacy and a reduction of side-effects, as compared to CsA. An intriguing hypothesis is that toxic damage could be due to a systemic CsA activation of arachidonic acid (AA) metabolism, through pathways as yet only partially characterized. The side-effects of both drugs have been poorly studied on cells from tissues other than blood or kidney. We have thus proceeded to study their action on AA release in corticotropic AtT-20/D16-16 cells. The results obtained are as follows: 1) during incubation times > or =12 h, basal AA release is increased by CsA, but not FK506; the acute effect (10 min) of melittin, a PLA2 activator, is significantly potentiated starting from a 30 min pretreatment with CsA but not FK506; manoalide, a PLA2 inhibitor, antagonizes the melittin potentiation of AA release by CsA whereas the inhibition of the melittin stimulus by glucocorticoids is antagonized both by CsA and FK506. 2) during longer (>2 d) incubation times, cell growth is inhibited by CsA but not FK506. These results indicate a role for CsA, not apparent for FK506, in the activation of PLA2 and in the inhibition of cell growth. They also suggest that CsA does not have a direct (i.e. not mediated by the immune system) therapeutic effect in inflammatory processes.


Subject(s)
Arachidonic Acid/metabolism , Cyclosporine/pharmacology , Immunosuppressive Agents/pharmacology , Phospholipases A/metabolism , Pituitary Neoplasms/metabolism , Tacrolimus/pharmacology , Animals , Cell Division/drug effects , Cell Size/drug effects , Cell Survival/drug effects , Cyclosporine/adverse effects , Dexamethasone/pharmacology , Digitonin/pharmacology , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Interleukin-1/pharmacology , Melitten/agonists , Melitten/antagonists & inhibitors , Melitten/pharmacology , Mice , Phospholipases A/antagonists & inhibitors , Phospholipases A2 , Pituitary Neoplasms/drug therapy , Pituitary Neoplasms/pathology , Tacrolimus/adverse effects , Terpenes/pharmacology , Time Factors , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/pharmacology , Vitamin E/pharmacology
9.
FEBS Lett ; 440(1-2): 99-102, 1998 Nov 27.
Article in English | MEDLINE | ID: mdl-9862434

ABSTRACT

Here we examine the application of the cisternal/carrier maturation model to describe transport of cargo proteins from the Golgi apparatus to the plasma membrane. Interpretation of the available evidence in the light of carrier maturation suggests that the transport intermediates between these stations are large pleiomorphic carriers formed by maturation of the trans-Golgi compartment, rather than vesicles, as would be postulated by the vesicular shuttle model. Mature carriers move along microtubules towards the plasma membrane via a microtubule/(kinesin)-based motor system. The maturation and vesicular transport models are compared in terms of consistency with the available literature.


Subject(s)
Biological Transport , Cell Membrane/metabolism , Golgi Apparatus/metabolism , Models, Biological , Carrier Proteins/metabolism , Coated Vesicles/metabolism , Cytoplasmic Granules/metabolism , Diffusion , Endosomes/metabolism , Golgi Apparatus/enzymology , Intracellular Membranes/metabolism , Kinesins/metabolism , Microtubules/metabolism
10.
Cell ; 95(7): 993-1003, 1998 Dec 23.
Article in English | MEDLINE | ID: mdl-9875853

ABSTRACT

Newly synthesized procollagen type I (PC) assembles into 300 nm rigid, rod-like triple helices in the lumen of the endoplasmic reticulum. This oligomeric complex moves to the Golgi and forms large electron-dense aggregates. We have monitored the transport of PC along the secretory pathway. We show that PC moves across the Golgi stacks without ever leaving the lumen of the Golgi cisternae. During transport from the endoplasmic reticulum to the Golgi, PC is found within tubular-saccular structures greater than 300 nm in length. Thus, supermolecular cargoes such as PC do not utilize the conventional vesicle-mediated transport to traverse the Golgi stacks. Our results imply that PC moves in the anterograde direction across the Golgi complex by a process involving progressive maturation of Golgi cisternae.


Subject(s)
Golgi Apparatus/metabolism , Procollagen/metabolism , 2,2'-Dipyridyl/pharmacology , Animals , Biological Transport/drug effects , Chick Embryo , Cytoplasmic Granules/metabolism , Endoplasmic Reticulum/chemistry , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum/ultrastructure , Fibroblasts , Fluorescent Antibody Technique , Golgi Apparatus/chemistry , Golgi Apparatus/ultrastructure , Intracellular Membranes/metabolism , Microscopy, Electron , Organelles/metabolism , Procollagen/chemistry , Procollagen/ultrastructure , Protein Binding , Protein Conformation , Protein Folding , Rats , Tendons , Time Factors
11.
J Biol Chem ; 272(22): 14200-7, 1997 May 30.
Article in English | MEDLINE | ID: mdl-9162051

ABSTRACT

Brefeldin A, a toxin inhibitor of vesicular traffic, induces the selective mono-ADP-ribosylation of two cytosolic proteins, glyceraldehyde-3-phosphate dehydrogenase and the novel GTP-binding protein BARS-50. Here, we have used a new quantitative assay for the characterization of this reaction and the development of specific pharmacological inhibitors. Mono-ADP-ribosylation is activated by brefeldin A with an EC50 of 17.0 +/- 3.1 microg/ml, but not by biologically inactive analogs including a brefeldin A stereoisomer. Brefeldin A acts by increasing the Vmax of the reaction, whereas it does not influence the Km of the enzyme for NAD+ (154 +/- 13 microM). The enzyme is an integral membrane protein present in most tissues and is modulated by Zn2+, Cu2+, ATP (but not by other nucleotides), pH, temperature, and ionic strength. To identify inhibitors of the reaction, a large number of drugs previously tested as blockers of bacterial ADP-ribosyltransferases were screened. Two classes of molecules, one belonging to the coumarin group (dicumarol, coumermycin A1, and novobiocin) and the other to the quinone group (ilimaquinone, benzoquinone, and naphthoquinone), rather potently and specifically inhibited brefeldin A-dependent mono-ADP-ribosylation. When tested in living cells, these molecules antagonized the tubular reticular redistribution of the Golgi complex caused by brefeldin A at concentrations similar to those active in the mono-ADP-ribosylation assay in vitro, suggesting a role for mono-ADP-ribosylation in the cellular actions of brefeldin A.


Subject(s)
Cyclopentanes/pharmacology , GTP-Binding Proteins/metabolism , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Protein Processing, Post-Translational/drug effects , Protein Synthesis Inhibitors/pharmacology , Adenosine Diphosphate , Animals , Brefeldin A , Cell Line , Male , Rats , Rats, Sprague-Dawley , Ribose , Structure-Activity Relationship , Tissue Distribution
12.
J Steroid Biochem Mol Biol ; 60(1-2): 51-7, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9182858

ABSTRACT

The biochemical basis of the short-term inhibitory effects of glucocorticoids on corticotropin release from pituitary corticotrophs is still obscure. A well-characterized effect of glucocorticoids in several cell types is the inhibition of arachidonic acid (AA) generation by phospholipase A2 (PLA2). Arachidonic acid and its metabolites have been implicated in the secretory process from a number of pituitary cells, such as the corticotrophs. We have thus examined the role of AA in the anti-secretagogue effects of glucocorticoids in a corticotropin-secreting clonal corticotroph line (AtT-20 D16/16). Glucocorticoids decreased AA release induced by melittin, a bee venom protein related to extracellular PLA2. When a possible role of AA in corticotropin release was studied, the following results were obtained: (a) all corticotropin secretagogues tested, including corticotropin-releasing factor (CRF), did not alter AA generation; (b) calcium and guanine nucleotides, which stimulate corticotropin release in permeabilized cells, inhibited the release of AA under the same conditions; (c) administration of melittin or of exogenous AA had no effect on basal and CRF-stimulated corticotropin release; (d) administration of large amounts of exogenous AA was unable to restore the ability to secrete corticotropin under suppression by glucocorticoids. Altogether, the data suggest that whereas glucocorticoids can inhibit both AA generation and corticotropin release, these two effects appear to be causally unrelated.


Subject(s)
Adrenocorticotropic Hormone/metabolism , Arachidonic Acid/metabolism , Glucocorticoids/pharmacology , Pituitary Gland/metabolism , Adrenocorticotropic Hormone/drug effects , Animals , Arachidonic Acid/pharmacology , Calcimycin/pharmacology , Cell Line , Corticotropin-Releasing Hormone/metabolism , Corticotropin-Releasing Hormone/pharmacology , Dexamethasone/pharmacology , Dose-Response Relationship, Drug , Glucocorticoids/metabolism , Isoproterenol/pharmacology , Melitten/pharmacology , Mice , Pituitary Gland/cytology , Pituitary Gland/drug effects , Potassium Chloride/pharmacology , Tetradecanoylphorbol Acetate/pharmacology
13.
Regul Pept ; 72(2-3): 169-77, 1997 Oct 31.
Article in English | MEDLINE | ID: mdl-9652977

ABSTRACT

The mechanism of short-term glucocorticoid (GC) inhibition of the hypothalamic-pituitary-adrenal axis is not well understood. The direct anti-inflammatory activities of lipocortins (LCs) have suggested a role for them as extra- and intracellular mediators of the biological effects of GCs. It has been reported that recombinant human (rh) LC1 inhibits corticotropin (ACTH) release from pituitary tissue in vitro but not from AtT-20 D16:16 corticotrophs. Using the same cell line we have tested whether other exogenous rhLCs or native LC extracted from polymorphonucleate neutrophils (neLC), likely LC1, have an effect on ACTH secretion. It is shown that: (1) basal release was not affected by a short-term incubation with neLC; (2) secretion induced by corticotropin-releasing factor (CRF) and other secretagogues (phorbol ester, potassium ion or calcium ionophore) was inhibited by neLC; (3) GC inhibition of CRF-stimulated release was reverted by a monoclonal anti-neLC antibody; (4) rhLC2, rhLC5 and the fragment 212-234 of rhLC5 were without effect. Thus, only neLC is effective on AtT-20 D16:16 cells, suggesting for this annexin a role in the early phase GC inhibition of ACTH secretion.


Subject(s)
Adrenocorticotropic Hormone/antagonists & inhibitors , Annexins/metabolism , Neutrophils/metabolism , Pituitary Gland/metabolism , Adrenocorticotropic Hormone/metabolism , Animals , Annexins/isolation & purification , Annexins/pharmacology , Antibodies, Monoclonal/pharmacology , Blotting, Western , Clone Cells/drug effects , Clone Cells/metabolism , Corticotropin-Releasing Hormone/metabolism , Corticotropin-Releasing Hormone/pharmacology , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Humans , Ionophores/metabolism , Ionophores/pharmacology , Mice , Mice, Nude , Neutrophils/immunology , Pituitary Gland/cytology , Pituitary Gland/drug effects , Potassium/metabolism , Potassium/pharmacology , Rabbits , Radioimmunoassay , Recombinant Proteins/pharmacology , Tetradecanoylphorbol Acetate/metabolism , Tetradecanoylphorbol Acetate/pharmacology
14.
J Biol Chem ; 271(7): 3523-33, 1996 Feb 16.
Article in English | MEDLINE | ID: mdl-8631957

ABSTRACT

Biochemical and morphometric approaches were combined to examine whether constitutive secretory transport might be controlled by plasma membrane receptors, as this possibility would have significant physiological implications. Indeed, IgE receptor stimulation in rat basophilic leukemia cells potently increased the rate of transport of soluble pulse-labeled 35S-sulfated glycosaminoglycans from distal Golgi compartments to the cell surface. This effect was largely protein kinase C (PKC)-dependent. Direct activation of PKC also stimulated constitutive transport of glycosaminoglycans, as indicated by the use of agonistic and antagonistic PKC ligands. PKC ligands also had potent, but different, effects on the exocytic transport from distal Golgi compartments to the plasma membrane of a membrane-bound protein (vesicular stomatitis virus glycoprotein), which was slightly stimulated by activators and profoundly suppressed by inhibitors of PKC. Morphological analysis showed impressive changes of the organelles of the secretory pathway in response to IgE receptor stimulation and to direct PKC activation (enhanced number of buds and vesicles originating from the endoplasmic reticulum and Golgi and increase in surface and volume of Golgi compartments), suggestive of an overall activation of exocytic movements. These results show that rapid and large changes in constitutive transport fluxes and in the morphology of the exocytic apparatus can be induced by membrane receptors (as well as by direct PKC stimulation).


Subject(s)
Cytoplasmic Granules/metabolism , Exocytosis , Glycosaminoglycans/metabolism , Proteoglycans/metabolism , Receptors, IgE/physiology , Animals , Cell Line , Cell Membrane/metabolism , Cell Nucleus/metabolism , Cell-Free System , Cytoplasmic Granules/ultrastructure , Dogs , Endoplasmic Reticulum/metabolism , Enzyme Activation , Exocytosis/drug effects , Glycosaminoglycans/biosynthesis , Glycosaminoglycans/isolation & purification , Golgi Apparatus/metabolism , HeLa Cells , Homeostasis , Humans , Kinetics , Leukemia, Basophilic, Acute/immunology , Leukemia, Basophilic, Acute/physiopathology , PC12 Cells , Protein Kinase C/biosynthesis , Protein Kinase C/metabolism , Proteoglycans/biosynthesis , Proteoglycans/isolation & purification , Rats , Sulfur Radioisotopes , Tetradecanoylphorbol Acetate/pharmacology , Tumor Cells, Cultured
15.
Biochem J ; 298 ( Pt 1): 149-56, 1994 Feb 15.
Article in English | MEDLINE | ID: mdl-8129713

ABSTRACT

The role of protein kinase C in calcium-dependent exocytosis was investigated in permeabilized rat basophilic leukaemia cells. When protein kinase C was down-regulated by phorbol myristate acetate (1 microM for 3-6 h) or inhibited by pharmacological agents such as calphostin C (1 microM) or a protein kinase C-specific pseudo-substrate peptide inhibitor (100-200 microM), cells lost the ability to secrete in response to 10 microM free Ca2+. In contrast, a short treatment (15 min) with phorbol myristate acetate, which maximally activates protein kinase C, potentiated the effects of calcium. Biochemical analysis of protein kinase C-deprived cells indicated that loss of the Ca(2+)-induced secretory response correlated with disappearance of protein kinase C-alpha. In addition, at the concentrations effective for exocytosis, calcium caused translocation of protein kinase C-alpha to the membrane fraction and stimulated phospholipase C, suggesting that, in permeabilized cells, protein kinase C can be activated by calcium through generation of the phospholipase C metabolite diacylglycerol. The delta, epsilon and zeta Ca(2+)-independent protein kinase C isoenzymes were insensitive to phorbol myristate acetate-induced down-regulation and did not, as expected, translocate to the particulate fraction in response to calcium. Interestingly, secretory competence was restored in cells depleted of protein kinase C or in which protein kinase C itself was inhibited by non-hydrolysable GTP analogues, but not by GTP, suggesting that protein kinase C might regulate the ability of a G protein(s) directly controlling the exocytotic machinery to be activated by endogenous GTP.


Subject(s)
Exocytosis , GTP-Binding Proteins/metabolism , Protein Kinase C/metabolism , Amino Acid Sequence , Animals , Calcium/metabolism , Cell Membrane Permeability , Down-Regulation , Enzyme Activation , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Isoenzymes/metabolism , Molecular Sequence Data , Rats , Substrate Specificity , Tumor Cells, Cultured , Type C Phospholipases/metabolism
16.
J Exp Zool ; 262(4): 391-404, 1992 Jul 01.
Article in English | MEDLINE | ID: mdl-1320658

ABSTRACT

Guanyl nucleotide binding-proteins, or G-proteins, are ubiquitous molecules that are involved in cellular signal transduction mechanisms. Because a role has been established for cAMP in meiosis and G-proteins participate in cAMP-generating systems by stimulating or inhibiting adenylate cyclase, the present study was conducted to examine the possible involvement of G-proteins in the resumption of meiotic maturation. Cumulus cell-free mouse oocytes (denuded oocytes) were maintained in meiotic arrest in a transient and dose-dependent manner when microinjected with the nonhydrolyzable GTP analog, GTP gamma S. This effect was specific for GTP gamma S, because GppNHp, GTP, and ATP gamma S were without effect. Three compounds, known to interact with G-proteins, were tested for their ability to modulate meiotic maturation: pertussis toxin, cholera toxin, and aluminum fluoride (AlF4-). Pertussis toxin had little effect on maturation in either cumulus cell-enclosed oocytes or denuded oocytes when meiotic arrest was maintained with dibutyryl cAMP (dbcAMP) or hypoxanthine. Cholera toxin stimulated germinal vesicle breakdown (GVB) in cumulus cell-enclosed oocytes during long-term culture, but its action was inhibitory in denuded oocytes. AlF4- stimulated GVB in both cumulus cell-enclosed oocytes and denuded oocytes when meiotic arrest was maintained with hypoxanthine but was much less effective in dbcAMP-arrested oocytes. In addition, AlF4- abrogated the inhibitory action of cholera toxin in denuded oocytes and also that of follicle-stimulating hormone (FSH) in cumulus cell-enclosed oocytes. Cholera toxin or FSH alone each stimulated the synthesis of cAMP in oocyte-cumulus cell complexes, whereas pertussis toxin or AlF4- alone were without effect. Both cholera toxin and AlF4- augmented the stimulatory action of FSH on cAMP. These data suggest the involvement of guanyl nucleotides and G-proteins in the regulation of GVB, although different G-proteins and mediators may be involved at the oocyte and cumulus cell levels. Cholera toxin most likely acts by ADP ribosylation of the alpha subunit of Gs and increased generation of cAMP, whereas AlF4- appears to act by antagonizing a cAMP-dependent step.


Subject(s)
Aluminum Compounds , GTP-Binding Proteins/physiology , Guanine Nucleotides/physiology , Oogenesis/physiology , Adenylate Cyclase Toxin , Aluminum/pharmacology , Animals , Bucladesine/pharmacology , Cells, Cultured , Cholera Toxin/pharmacology , Female , Fluorides/pharmacology , Follicle Stimulating Hormone/pharmacology , Guanosine 5'-O-(3-Thiotriphosphate) , Guanosine Triphosphate/analogs & derivatives , Guanosine Triphosphate/physiology , Hypoxanthine , Hypoxanthines/pharmacology , Mice , Mice, Inbred C57BL , Microinjections , Ovarian Follicle/physiology , Pertussis Toxin , Virulence Factors, Bordetella/pharmacology , Zona Pellucida/physiology
17.
J Biol Chem ; 266(16): 10452-60, 1991 Jun 05.
Article in English | MEDLINE | ID: mdl-1645349

ABSTRACT

Strong, albeit indirect, evidence suggests that a GTP-binding (G) protein(s) can act directly on the secretory machinery by a post-second messenger mechanism. The type and function of this putative Ge (exocytosis) protein were investigated in streptolysin-O-permeabilized rat basophilic leukemia (RBL) cells. The exocytotic response to calcium was first characterized both morphologically and biochemically using the release of preloaded [3H]serotonin as an index of exocytosis. Calcium-induced secretion (EC50 about 3 microM) in RBL cells requires ATP (EC50 about 2.5 mM) and is modulated by pH, the optimal value being 7.2. Another requirement for calcium-induced secretion is an activated G protein, since inactivators of G proteins such as GDP beta S (EC50 about 800 microM) inhibit the secretagogue effect of 10 microM free calcium. Conversely, GTP gamma S (EC50 about 1 microM) and other nonhydrolyzable analogs of GTP, which keep G proteins in a permanently active conformation, potentiate the effect of calcium. GTP gamma S alone is without effect. The effect of GTP gamma S on exocytosis is apparently not mediated by known second messengers, suggesting that a Ge protein is involved. Electron microscopic images show that in resting cells, secretory granules are clustered in the perinuclear area, whereas they become scattered upon calcium stimulation. A paradoxical effect of GTP gamma S is observed when applied during permeabilization; under these conditions, in fact, the nucleotide inhibits the subsequent secretory response to calcium. The scattering of granules is also inhibited. This effect of GTP gamma S is counteracted by coadministration of GTP. These responses to guanine nucleotides are typical of vectorially acting G proteins involved in protein synthesis and in intracellular vesicle transport. Taken together, the data presented suggest that calcium-dependent release requires a vectorially acting G protein controlling the movement of secretory granules. This and alternative models are discussed.


Subject(s)
Calcium/metabolism , GTP-Binding Proteins/physiology , Leukemia, Experimental/metabolism , Alkaloids/pharmacology , Animals , Cyclic AMP/pharmacology , Cytoplasmic Granules/metabolism , Cytoplasmic Granules/ultrastructure , Exocytosis , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Hydrogen-Ion Concentration , Leukemia, Experimental/pathology , Microscopy, Electron , Protein Kinase C/analysis , Proteoglycans/metabolism , Rats , Serotonin Antagonists/metabolism , Serotonin Antagonists/pharmacology , Staurosporine , Tumor Cells, Cultured/ultrastructure
18.
J Exp Zool ; 258(2): 249-54, 1991 May.
Article in English | MEDLINE | ID: mdl-2022950

ABSTRACT

The role of granulosa cells in the regulation of mouse ovarian oocyte metabolism was investigated. Fully grown antral oocytes, isolated from surrounding cumulus cells, were cultured on monolayers of preantral granulosa cells in the presence of dbcAMP to prevent the resumption of meiosis. Under these conditions metabolic cooperativity was established between the two cell types as early as 1 hr after seeding. Moreover, cocultured oocytes phosphorylated two polypeptides of 74 and 21 kDa which are normally phosphorylated in follicle-enclosed growing oocytes but not in cumulus cell-enclosed fully grown oocytes at the germinal vesicle stage. When cocultured oocytes were allowed to resume meiosis, the 74 and 21 kDa proteins were synthesized but no longer phosphorylated even though intercellular coupling between the two cell types was maintained during radiolabeling. It appears therefore: a) that the different protein kinase activity of growing and fully grown germinal vesicle-stage mouse oocytes is related to the differentiative state of granulosa cells, and b) that the regulation of oocyte protein phosphorylation activity by granulosa cells is dependent on the meiotic stage of the oocyte.


Subject(s)
Granulosa Cells/physiology , Oocytes/metabolism , Animals , Cell Communication , Cell Differentiation , Cell Separation , Cells, Cultured , Electrophoresis, Gel, Two-Dimensional , Female , Granulosa Cells/cytology , Mice , Mice, Inbred Strains , Peptides/metabolism , Phosphoproteins/metabolism , Phosphorus Radioisotopes , Phosphorylation
19.
Biol Reprod ; 43(4): 543-7, 1990 Oct.
Article in English | MEDLINE | ID: mdl-2289008

ABSTRACT

Oocytes and their companion somatic cells maintain a close association throughout oogenesis and this association is essential for normal oocyte and follicular development. This review summarizes current concepts of the role of the somatic cells in the regulation of mammalian oocyte growth, the maintenance of meiotic arrest, the induction of oocyte maturation, and the acquisition of full embryonic developmental competence during oocyte maturation in vitro. Gap junctions appear to mediate these regulatory processes. The regulatory interaction of oocytes and somatic cells, however, is not unidirectional; the oocyte participates in the proliferation, development, and function of the follicular somatic cells. The oocyte secretes factors that enable the cumulus cells to synthesize hyaluronic acid and undergo cumulus expansion in response to hormonal stimulation. In addition, the oocyte produces factors that promote the proliferation of granulosa cells. These interactions in vitro do not appear to require the mediation of gap junctions. The oocyte also promotes the differentiation of granulosa cells into functional cumulus cells, but this function of the oocyte appears to require the continued presence and close association of the oocyte and granulosa cells. Therefore, oocytes and follicular somatic cells are interdependent for development and function.


Subject(s)
Cell Communication/physiology , Granulosa Cells/cytology , Oocytes/cytology , Oogenesis/physiology , Animals , Female , Granulosa Cells/physiology , Mice , Oocytes/physiology
20.
Dev Biol ; 140(2): 307-17, 1990 Aug.
Article in English | MEDLINE | ID: mdl-2115479

ABSTRACT

The expansion, or mucification, of the mouse cumulus oophorus in vitro requires the presence of an enabling factor secreted by the oocyte as well as stimulation with follicle-stimulating hormone (FSH). This study focuses on (1) the ability of mouse oocytes to secrete the enabling factor at various times during oocyte growth and maturation, (2) the temporal relationships between the development of the capacity of the oocyte to undergo germinal vesicle breakdown, the ability of the oocyte to secrete cumulus expansion-enabling factor, and the capacity of the cumulus oophorus to undergo expansion, and (3) the role of the oocyte in the differentiation of granulosa cells as functional cumulus cells. Growing, meiotically incompetent oocytes did not produce detectable amounts of cumulus expansion-enabling factor, but fully grown meiosis-arrested oocytes, maturing oocytes, and metaphase II oocytes did. Detectable quantities of enabling factor were produced by zygotes, but not by two-cell stage to morula embryos. The ability of oocytes to secrete cumulus expansion enabling factor and the capacity of cumulus cells to respond to FSH and the enabling factor are temporally correlated with the acquisition of oocyte competence to undergo germinal vesicle breakdown. Mural granulosa cells of antral follicles do not expand in response to FSH even in the presence of cumulus expansion-enabling factor, showing that mural granulosa cells and cumulus cells are functionally distinct cell types. The perioocytic granulosa cells of preantral follicles isolated from 12-day-old mice differentiate into functional cumulus cells during a 7-day period in culture. Oocytectomized granulosa cell complexes grown in medium conditioned by either growing or fully grown oocytes were comparable in size to intact complexes and maintained their 3-dimensional integrity to a greater degree than oocytectomized complexes grown in unconditioned medium. After 7 days, the oocytectomized complexes were stimulated with FSH in the presence of enabling factor, but no expansion was observed whether or not the oocytectomized complexes grew in the presence of oocyte-conditioned medium. These results suggest that a factor(s) secreted by the oocyte affects granulosa cell proliferation and the structural organization of the follicle, but continual close association with the oocyte appears necessary for the differentiation of granulosa cells into functional cumulus cells, insofar as they are capable of undergoing expansion.


Subject(s)
Biological Factors/physiology , Granulosa Cells/physiology , Oocytes/physiology , Animals , Biological Factors/metabolism , Cell Communication , Cell Differentiation , Female , Follicle Stimulating Hormone/pharmacology , Granulosa Cells/cytology , Granulosa Cells/drug effects , In Vitro Techniques , Intercellular Junctions/ultrastructure , Meiosis , Mice , Mice, Inbred Strains , Microscopy, Electron, Scanning , Oocytes/cytology , Ovarian Follicle/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...